Skip to main navigation Skip to search Skip to main content

Prospects for Leveraging the Microbiota as Medicine for Hypertension

  • David J. Durgan
  • , Jasenka Zubcevic
  • , Matam Vijay-Kumar
  • , Tao Yang
  • , Ishan Manandhar
  • , Sachin Aryal
  • , Rikeish R. Muralitharan
  • , Hong Bao Li
  • , Ying Li
  • , Justine M. Abais-Battad
  • , Jennifer L. Pluznick
  • , Dominik N. Muller
  • , Francine Z. Marques
  • , Bina Joe
  • Baylor College of Medicine
  • Center for Hypertension and Precision Medicine
  • Microbiome Consortium
  • University of Toledo
  • Monash University
  • Baker Heart and Diabetes Institute
  • Xi'an Jiaotong University
  • Augusta University
  • Johns Hopkins University
  • Max Delbrück Center for Molecular Medicine in the Helmholtz Association
  • Charité – Universitätsmedizin Berlin
  • German Centre for Cardiovascular Research

Research output: Contribution to journalReview articlepeer-review

16 Scopus citations
Original languageEnglish
Pages (from-to)951-963
Number of pages13
JournalHypertension
Volume81
Issue number5
DOIs
StatePublished - 1 May 2024

Keywords

  • blood pressure
  • essential hypertension
  • heart diseases
  • inventions
  • microbiota

Cite this